Xellia Pharmaceuticals is shedding its manufacturing operation in Bedford to a British manufacturer of pharmaceutical products. The Danish company that operates locally at the ex-Ben Venue ...

Hikma Pharmaceuticals has agreed to buy the massive Ben Venue Laboratories complex and its research and development team — but will Hikma bring the troubled facility back to life?

London, 15 May 2025 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, is today hosting sell-side analysts and investors at its US manufacturing and R&D facility in ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

London, 6 November 2025 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. We are making good progress in the second half, ...

Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws. The acquisition includes ...

The boss of FTSE 100 giant Hikma Pharmaceuticals will be replaced by the firm’s former top chief after the group’s share price dropped by nearly a quarter this year. Riad Mishlawi has exited his role ...

AMMAN — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, and its “long-standing” partner Celltrion Inc., a global biopharmaceutical leader, have signed exclusive licensing ...

Pharma group Hikma laid out its trading performance in the first half of the year ahead of its AGM later today. The company said this morning that it remained on track to report revenue growth of four ...

Hikma is offering triamcinolone acetonide injectable suspension in a 40mg/ml dose. The product is indicated for various inflammatory, autoimmune, hormonal and other conditions where a corticosteroid ...

LONDON, April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application ...